Lotus Pharmaceuticals, Inc. (LTUS)
Develops and sells pharmaceuticals in China.
$0.00+0.00%Financial Services
StockGlow Score
Bearish
BearishBullish
1 year ago-68.4%
The outlook
LTUS is trading near its 52-week low and well below both its 50- and 200-day moving averages, reflecting a downtrend over recent months. Analyst coverage appears minimal or unavailable. The overall sentiment here is bearish, with the stock positioned in the lower end of its yearly range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range15% of the way from its 52-week low to high
Market cap
$7.9M
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—